Correlation of the frequency of petite formation by isolates of Saccharomyces cerevisiae with virulence

References

• Aucott JN, Fayen J, Grossnicklas H, Morrissey A, Lederman MM, Salata RA. Invasive infection with Saccharomyces cerevisiae: report of three cases and review. Rev Infect Dis 1990; 12: 406–411.
   PubMedGoogle Scholar
• Cimolai N, Gill MJ, Church D. Saccharomyces cerevisiae fungemia: case report and review of the literature. Diagn Micro biol Infect Dis 1987; 8: 117.
   Google Scholar
• Clemons KY, McCusker JH, Davis RW, Stevens DA. Com-parative pathogenesis of clinical and nonclinical isolates of Saccharomyces cerevisiae. J Infect Dis 1994; 169: 859–867.
   PubMed Web of Science ®Google Scholar
• Byron JK, Clemons KY, McCusker JH, Davis RW, Stevens DA. Pathogenicity of Saccharomyces cerevisiae in complement factor five-deficient mice. Infect Immun 1995; 63: 478–485.
   Google Scholar
• Hector RF, Domer JE, Carrow EW. Immune responses to Candida albicans in genetically distinct mice. Infect Immun 1982; 38: 1020–1028.
   PubMed Web of Science ®Google Scholar
• Hector RF, Yee E, Collins MS. Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillo-sis. Infect Immun 1990; 58: 1476–1478.
   Google Scholar
• Lyon FL, Hector RF, Domer JE. Innate and acquired immune responses against Candida albicans in congenic B1O.D2 mice with deficiency of the C5 complement component. J Med Vet Mycol 1986; 24: 359–367.
   Google Scholar
• Miller ME, Nilsson UR. A familial deficiency of the phagocy-tosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5). N Engl J Med 1970; 282: 354–358.
   PubMed Web of Science ®Google Scholar
• Morelli R, Rosenberg LT. The role of complement in the phagocytosis of Candida albicans by mouse peripheral blood leukocytes. J Immuno11971; 107:476–480.
   PubMed Web of Science ®Google Scholar
• Rhodes JC, Wicker LS, Urba WJ. Genetic control of suscept-ibility to Cryptococcus neoformans in mice. Infect Immun 1980; 29: 494–499.
   Google Scholar
• Rhodes JC. Contribution of complement component CS to the pathogenesis of experimental murine cryptococcosis. Sabour-audia 1985; 23: 225–234.
   PubMedGoogle Scholar
• Washburn R, Julian N. Congentially CS-deficient mice have increased susceptibility to invasive aspergillosis. In: Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, LA: American Society for Microbiology, Washington, D.C., 1993: 129.
   Google Scholar
• Clemons KY, Hanson LC, Stevens DA. Colony phenotype switching in clinical and non-clinical isolates of Saccharomyces cerevisiae. J Med Vet Mycol 1996; 34: 259–264.
   Google Scholar
• McCusker JH, Clemons KY, Stevens DA, Davis RW. Genetic characterization of pathogenic Saccharomyces cerevisiae iso-lates. Genetics 1994; 136: 1261–1269.
   PubMed Web of Science ®Google Scholar
• Aoki S, Ito-Kuwa S, Nakamura Y, Masuhara T. Comparative pathogenicity of a wild-type strain and respiratory mutants of Candida albicans in mice. Zentralbl Bakteriol 1990; 273: 332–343.
   PubMedGoogle Scholar
• Hanson LH, Stevens DA. Comparison of antifungal activity of amphotericin B deoxycholate suspension with that of ampho-tericin B cholesteryl sulfate colloidal dispersion. Antimicrob Agents Chemother 1992; 36: 486–488.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Refer-ence Method for Broth Dilution Antifungal Susceptibility Testing of Yeast. Approved Standard. Wayne, PA.: 1st National Committee for Clinical Labratory Standards, 1997.
   Google Scholar
• Sokal RR, Rohlf FJ. Biometry. In: Biometry. 2nd edn. San Francisco, CA: W. H. Freeman & Co., 1981: 432–435.
   Google Scholar
• Hostetler JS, Clemons KY, Hanson LH, Stevens DA. Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosis. Antimicrob Agents Chemother 1992; 36: 2656–2660.
   PubMed Web of Science ®Google Scholar
• McCusker JH, Clemons KY, Stevens DA, Davis RW. Sacchar-omyces cerevisiae virulence phenotype as determined with CD-1 mice is associated with the ability to grow at 42 degrees C and form pseudohyphae. Infect Immun 1994; 62: 5447–5455.
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP. Modulation of fluconazole sensitivity by the interaction of mitochondria and erg3p in Saccharomyces cerevisiae. J Antimicrob Chemother 2000; 46: 191–197.
   PubMed Web of Science ®Google Scholar